Complement in host deficiencies and diseases

Clinical Immunology: Principles and Practice: Fourth Edition

Volumn , Issue , 2013, Pages 252-269

  Du Clos, Terry W ^a,b   Mold, Carolyn ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934967242     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7234-3691-1.00041-6     Document Type: Chapter

References (65)

1. Ricklin D., Hajishengallis G., Yang K., et al. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010, 11:785-797.
2. Marnell L., Mold C., Du Clos T.W. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 2005, 117:104-111.
3. Kang Y.S., Do Y., Lee H.K., et al. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 2006, 125:47-58.
4. Ravetch J.V., Clynes R.A. Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 1998, 16:421-432.
5. Brown J.S., Hussell T., Gilliland S.M., et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci U S A 2002, 99:16969-16974.
6. Sorensen R., Thiel S., Jensenius J.C. Mannan-binding-lectin-associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol 2005, 27:299-319.
7. Spitzer D., Mitchell L.M., Atkinson J.P., et al. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol 2007, 179:2600-2608.
8. Lachmann P.J. The amplification loop of the complement pathways. Adv Immunol 2009, 104:115-149.
9. Janssen B.J., Christodoulidou A., McCarthy A., et al. Structure of C3b reveals conformational changes that underlie complement activity. Nature 2006, 444:213-216.
10. Abdul Ajees A., Gunasekaran K., Volanakis J.E., et al. The structure of complement C3b provides insights into complement activation and regulation. Nature 2006, 444:221-225.
11. Wiesmann C., Katschke K.J., Yin J., et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 2006, 444:217-220.
12. Gaboriaud C., Juanhuix J., Gruez A., et al. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem 2003, 278:46974-46982.
13. Gaboriaud C., Thielens N.M., Gregory L.A., et al. Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol 2004, 25:368-373.
14. Dodds A.W., Ren X.D., Willis A.C., et al. The reaction mechanism of the internal thioester in the human complement component C4. Nature 1996, 379:177-179.
15. Matsushita M. Ficolins: complement-activating lectins involved in innate immunity. J Innate Immun 2010, 2:24-32.
16. Takahashi M., Ishida Y., Iwaki D., et al. Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D. J Exp Med 2010, 207:29-37.
17. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nat Rev Microbiol 2008, 6:132-142.
18. Cole D.S., Morgan B.P. Beyond lysis: how complement influences cell fate. Clin Sci (London) 2003, 104:455-466.
19. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol 2009, 9:729-740.
20. Zuraw B.L. Clinical practice. Hereditary angioedema. N Engl J Med 2008, 359:1027-1036.
21. Giannakis E., Jokiranta T.S., Male D.A., et al. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur J Immunol 2003, 33:962-969.
22. Manuelian T. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 2003, 111:1181-1190.
23. Morgan H.P., Schmidt C.Q., Guariento M., et al. Structural basis for engagement by complement factor H of C3b on a self surface. Nat Struct Mol Biol 2011, 18:463-470.
24. Kim D., Song W. Membrane complement regulatory proteins. Clin Immunol 2006, 118:127-136.
25. Inal J.M., Hui K.M., Miot S., et al. Complement C2 receptor inhibitor trispanning: a novel human complement inhibitory receptor. J Immunol 2005, 174:356-366.
26. Bohlson S.S., Fraser D.A., Tenner A.J. Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions. Mol Immunol 2007, 44:33-43.
27. Roozendaal R., Carroll M.C. Complement receptors CD21 and CD35 in humoral immunity. Immunol Rev 2007, 219:157-166.
28. van Lookeren Campagne M., Wiesmann C., Brown E.J. Macrophage complement receptors and pathogen clearance. Cell Microbiol 2007, 9:2095-2102.
29. Helmy K.Y., Katschke K.J., Gorgani N.N., et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006, 124:915-927.
30. Huber-Lang M., Sarma J.V., Zetoune F.S., et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006, 12:682-687.
31. Klos A., Tenner A.J., Johswich K.-O., et al. The role of the anaphylatoxins in health and disease. Mol Immunol 2009, 46:2753-2766.
32. Ward P.A. Functions of C5a receptors. J Mol Med 2009, 87:375-378.
33. Gerard N.P., Lu B., Liu P., et al. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J Biol Chem 2005, 280:39677-39680.
34. Rittirsch D., Flierl M.A., Nadeau B.A., et al. Functional roles for C5a receptors in sepsis. Nat Med 2008, 14:551-557.
35. Kumar V., Ali S.R., Konrad S., et al. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice. J Clin Invest 2006, 116:512-520.
36. Holers V.M., Kulik L. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation. Mol Immunol 2007, 44:64-72.
37. Kopf M., Abel B., Gallimore A., et al. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med 2002, 8:373-378.
38. Kemper C., Chan A.C., Green J.M., et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421:388-392.
39. Hawlisch H., Kohl J. Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol Immunol 2006, 43:13-21.
40. Thurman J.M., Holers V.M. The central role of the alternative complement pathway in human disease. J Immunol 2006, 176:1305-1310.
41. Taylor P.R., Carugati A., Fadok V.A., et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000, 192:359-366.
42. Poon I.K., Hulett M.D., Parish C.R. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ 2010, 17:381-397.
43. Du Clos T.W., Mold C. Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcgamma receptors. Curr Opin Organ Transplant 2010, Dec 9 [Epub ahead of print].
44. Fadok V.A., Bratton D.L., Henson P.M. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 2001, 108:957-962.
45. Gershov D., Kim S., Brot N., et al. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 2000, 192:1353-1364.
46. Mold C., Gewurz H., Du Clos T.W. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999, 42:23-30.
47. Riley-Vargas R.C., Lanzendorf S., Atkinson J.P. Targeted and restricted complement activation on acrosome-reacted spermatozoa. J Clin Invest 2005, 115:1241-1249.
48. Sjoholm A.G., Jonsson G., Braconier J.H., et al. Complement deficiency and disease: an update. Mol Immunol 2006, 43:78-85.
49. Wen L., Atkinson J.P., Giclas P.C. Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 2004, 113:585-593. quiz 594.
50. Reis E.S., Falcao D.A., Isaac L. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol 2006, 63:155-168.
51. Parker C., Omine M., Richards S., et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005, 106:3699-3709.
52. Kavanagh D., Richards A., Atkinson J. Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 2008, 59:293-309.
53. Noris M., Remuzzi G. Atypical hemolytic uremic syndrome. N Engl J Med 2009, 361:1676-1687.
54. Hecker L.A., Edwards A.O., Ryu E., et al. Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum Mol Genet 2009, 19:209-215.
55. Okemefuna A.I., Nan R., Miller A., et al. Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations. J Biol Chem 2010, 285:1053-1065.
56. Glovsky M.M., Ward P.A., Johnson K.J. Complement determinations in human disease. Ann Allergy Asthma Immunol 2004, 93:513-522. quiz 523-515, 605.
57. Shushakova N., Skokowa J., Schulman J., et al. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest 2002, 110:1823-1830.
58. Holers V.M., Girardi G., Mo L., et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002, 195:211-220.
59. Lesher A.M., Song W.-C. Review: Complement and its regulatory proteins in kidney diseases. Nephrology 2010, 15:663-675.
60. Seelen M.A., Roos A., Daha M.R. Role of complement in innate and autoimmunity. J Nephrol 2005, 18:642-653.
61. Roos A., Rastaldi M.P., Calvaresi N., et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006, 17:1724-1734.
62. Hawlisch H., Wills-Karp M., Karp C.L., et al. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol Immunol 2004, 41:123-131.
63. Kolev M.V., Ruseva M.M., Harris C.L., et al. Implication of complement system and its regulators in Alzheimer's disease. Curr Neuropharmacol 2009, 7:1-8.
64. Fonseca M.I., Chu S.-H., Berci A.M., et al. Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease. J Neuroinflammation 2011, 8:4.
65. Ehrnthaller C., Ignatius A., Gebhard F., et al. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med 2011, 17:317-329.